176 related articles for article (PubMed ID: 19657410)
1. Kawasaki disease at British Columbia's Children's Hospital.
Ebbeson RL; Riley MR; Potts JE; Human DG; Malleson PN
Paediatr Child Health; 2004 Sep; 9(7):466-70. PubMed ID: 19657410
[TBL] [Abstract][Full Text] [Related]
2. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
3. Kawasaki disease in Sicily: clinical description and markers of disease severity.
Maggio MC; Corsello G; Prinzi E; Cimaz R
Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Kawasaki Disease Children With Spontaneous Defervescence Within 10 Days.
Hu YC; Liu HM; Lin MT; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
Front Pediatr; 2019; 7():158. PubMed ID: 31069204
[No Abstract] [Full Text] [Related]
5. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
6. Cost-effective use of echocardiography in children with Kawasaki disease.
Scott JS; Ettedgui JA; Neches WH
Pediatrics; 1999 Nov; 104(5):e57. PubMed ID: 10545583
[TBL] [Abstract][Full Text] [Related]
7. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
Sittiwangkul R; Pongprot Y; Silvilairat S; Phornphutkul C
Singapore Med J; 2006 Sep; 47(9):780-4. PubMed ID: 16924360
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
Pilania RK; Jindal AK; Johnson N; Prithvi A; Vignesh P; Suri D; Rawat A; Gupta A; Singh S
Rheumatology (Oxford); 2021 Jul; 60(7):3413-3419. PubMed ID: 33221920
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
[TBL] [Abstract][Full Text] [Related]
10. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
Tavli V; Yilmazer MM; Güven B; Meşe T; Oner T; Demirpençe S
Turk Kardiyol Dern Ars; 2010 Jan; 38(1):20-4. PubMed ID: 20215838
[TBL] [Abstract][Full Text] [Related]
12. Complete and incomplete Kawasaki disease: Clinical differences and coronary artery outcome from a national prospective surveillance study in Switzerland.
Bressieux-Degueldre S; Gradoux E; Di Bernardo S; Sekarski N
Front Pediatr; 2023; 11():1137841. PubMed ID: 37020652
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid treatment of refractory Kawasaki disease.
Lang BA; Yeung RS; Oen KG; Malleson PN; Huber AM; Riley M; Ebbeson R; Ramsey SE; Laxer RM; Silverman ED; McCrindle BW; Ratnapalan S; Feldman BM
J Rheumatol; 2006 Apr; 33(4):803-9. PubMed ID: 16583481
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 942 cases of Kawasaki disease].
Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
[TBL] [Abstract][Full Text] [Related]
15. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J; Liu P; Hu W; Xu Y; Deng J
Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin for Kawasaki disease: a 3-year retrospective audit.
Pascall B; Thakker A; Foo Y; Thakker P
BMJ Paediatr Open; 2019; 3(1):e000451. PubMed ID: 31548996
[TBL] [Abstract][Full Text] [Related]
17. Jaundice-predominant manifestation of Kawasaki disease in children.
Huang YN; Lin CY; Chi H; Chiu NC; Huang DT; Chang L; Kung YH; Huang CY
Front Pediatr; 2023; 11():1281909. PubMed ID: 38264503
[TBL] [Abstract][Full Text] [Related]
18. Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals.
Goswami N; Marzan K; De Oliveira E; Wagner-Lees S; Szmuszkovicz J
Children (Basel); 2018 Nov; 5(11):. PubMed ID: 30469337
[TBL] [Abstract][Full Text] [Related]
19. Atypical Kawasaki Disease Complicated With Coronary Artery Aneurysm: A Case Report and Review of Literature.
Tanti SK; Mishra S
Cureus; 2021 Feb; 13(2):e13589. PubMed ID: 33815991
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Demographic, Clinical, and Echocardiographic Features Between Complete and Incomplete, and Early and Late Presenters of Kawasaki Disease: A 10-Year Single-Center Experience.
Kolko N; Bhat YA; Al Mesned A; Al Qwaee A; Al Akhfash A; Alhobani M; Al Anazi I
Cureus; 2023 Sep; 15(9):e45819. PubMed ID: 37876391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
